Please use this identifier to cite or link to this item:
Title: The intensive care medicine research agenda on multidrug-resistant bacteria, antibiotics, and stewardship.
Authors: Kollef, Marin H
Bassetti, Matteo
Francois, Bruno
Burnham, Jason
Dimopoulos, George
Garnacho-Montero, Jose
Lipman, Jeffrey
Luyt, Charles-Edouard
Nicolau, David P
Postma, Maarten J
Torres, Antonio
Welte, Tobias
Wunderink, Richard G
Keywords: Antibiotics;Bacteria;Multidrug resistance;Stewardship
metadata.dc.subject.mesh: Anti-Bacterial Agents
Antimicrobial Stewardship
Biomedical Research
Critical Care
Critical Illness
Cross Infection
Drug Resistance, Multiple, Bacterial
Intensive Care Units
Process Assessment, Health Care
Standard of Care
Issue Date: 4-Feb-2017
Abstract: To concisely describe the current standards of care, major recent advances, common beliefs that have been contradicted by recent trials, areas of uncertainty, and clinical studies that need to be performed over the next decade and their expected outcomes with regard to the management of multidrug-resistant (MDR) bacteria, antibiotic use, and antimicrobial stewardship in the intensive care unit (ICU) setting. Narrative review based on a systematic analysis of the medical literature, national and international guidelines, and expert opinion. The prevalence of infection of critically ill patients by MDR bacteria is rapidly evolving. Clinical studies aimed at improving understanding of the changing patterns of these infections in ICUs are urgently needed. Ideal antibiotic utilization is another area of uncertainty requiring additional investigations aimed at better understanding of dose optimization, duration of therapy, use of combination treatment, aerosolized antibiotics, and the integration of rapid diagnostics as a guide for treatment. Moreover, there is an imperative need to develop non-antibiotic approaches for the prevention and treatment of MDR infections in the ICU. Finally, clinical research aimed at demonstrating the beneficial impact of antimicrobial stewardship in the ICU setting is essential. These and other fundamental questions need to be addressed over the next decade in order to better understand how to prevent, diagnose, and treat MDR bacterial infections. Clinical studies described in this research agenda provide a template and set priorities for investigations that should be performed in this field.
metadata.dc.identifier.doi: 10.1007/s00134-017-4682-7
Appears in Collections:Producción 2020

Files in This Item:
There are no files associated with this item.

This item is protected by original copyright

Except where otherwise noted, Items on the Andalusian Health Repository site are licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives License.